# Manisha Sahay

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/manisha-sahay/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,389 |
| Field | Dialysis and Renal Disease Management |
| h-index | 27 |
| i10-index | 65 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5036331218 |
| ORCID iD | 0000-0001-5534-2516 |
| Works | 234 |

## Researcher papers

- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy](https://scholariq.org/papers/a-phase-2-trial-of-sibeprenlimab-in-patients-with-iga-nephropathy/)
- [Hyponatremia: A practical approach](https://scholariq.org/papers/hyponatremia-a-practical-approach/)
- [Increasing access to integrated ESKD care as part of universal health coverage](https://scholariq.org/papers/increasing-access-to-integrated-eskd-care-as-part-of-universal-health-coverage/)
- [Rickets-vitamin D deficiency and dependency](https://scholariq.org/papers/rickets-vitamin-d-deficiency-and-dependency/)
- [A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial](https://scholariq.org/papers/a-novel-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-gsk1278863-for/)
- [Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes](https://scholariq.org/papers/capturing-and-monitoring-global-differences-in-untreated-and-treated-end-stage/)
- [Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease](https://scholariq.org/papers/effect-of-sglt2-inhibitors-on-stroke-and-atrial-fibrillation-in-diabetic-kidney/)
- [The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics](https://scholariq.org/papers/the-indian-chronic-kidney-disease-ickd-study-baseline-characteristics/)
- [Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial](https://scholariq.org/papers/design-and-baseline-characteristics-of-the-finerenone-in-addition-to-standard-of/)
- [State-of-Art Therapeutics in IgA Nephropathy](https://scholariq.org/papers/state-of-art-therapeutics-in-iga-nephropathy/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.